Ann: Receipt of R&D Tax Rebate, page-31

I agree with you. It just seems odd that the company tends to just mention PTX200 as an after thought to pronouncements on PTX100.

Take for instance the last quarterly release the only mention of PTX200 is "Prescient also continued its work on PTX-200 trials during the period". Perhaps the company feels that it doesn't need to repeat what has already been said but you would think for a company trying to attract new shareholders that some regurgitated information may have been forthcoming? It just gives the impression that PTX200 is no longer #1 focus - why is that? Because there is nothing to add at this point (perfectly reasonable and my own personal take on the situation) or because the trials are failing and the company is now downplaying PTX200 - my belief is that some shareholders have taken this view and sold.